Preferential recognition of isocitrate dehydrogenase by a rabbit monoclonal antibody (ab124797) against the C-terminal peptide of RANKL

Journal of Immunological Methods
Kazue TerasawaMiki Hara-Yokoyama

Abstract

A rabbit monoclonal antibody (Abcam ab124797), with high affinity for a synthetic peptide corresponding to the C-terminal region of the receptor activator of nuclear factor (NF)-κB ligand (RANKL), specifically recognizes a 37 kDa protein by immunoblotting, in good agreement with the molecular mass of RANKL. However, our mass spectroscopy analysis revealed that the protein recognized by the antibody is the α-subunit of NAD(+)-dependent isocitrate dehydrogenase (ICDH), a key Krebs cycle enzyme in mitochondria. Consistently, immunocytochemical staining with the antibody revealed a network organization characteristic of mitochondria, which overlapped with staining by MitoTracker and was lost after the siRNA-mediated downregulation of ICDH. The C-terminal peptide of ICDH contains similar chemical characteristics to that of the RANKL peptide and interacts with the antibody, although the affinity is a hundred times weaker. The present study provides an example of the preferential recognition of a surrogate protein by a rabbit monoclonal antibody.

References

Sep 26, 1995·Proceedings of the National Academy of Sciences of the United States of America·H Spieker-PoletK L Knight
Dec 26, 2001·The Journal of Biological Chemistry·Shuichiro ItoTadashi Hata
Nov 5, 2004·Nature·Akiko KumaNoboru Mizushima
Feb 8, 2008·The Journal of Biological Chemistry·Alexander B TaylorLee McAlister-Henn
Dec 20, 2011·Methods : a Companion to Methods in Enzymology·N H TrierG Houen
Sep 24, 2014·Experimental Cell Research·Anupama R RajapaksheMiki Hara-Yokoyama

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Takashi Matsushima
© 2021 Meta ULC. All rights reserved